Millennium Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $122M | Sell |
132,900
-14,700
| -10% | -$14.9M | 0.05% | 366 |
|
|
2025
Q4 | $159M | Sell |
147,600
-8,600
| -6% | -$8.22M | 0.07% | 267 |
|
|
2025
Q3 | $119M | Sell |
156,200
-50,200
| -24% | -$37.4M | 0.05% | 355 |
|
|
2025
Q2 | $161M | Buy |
206,400
+12,700
| +7% | +$9.87M | 0.08% | 228 |
|
|
2025
Q1 | $160M | Buy |
193,700
+23,000
| +13% | +$19.1M | 0.09% | 206 |
|
|
2024
Q4 | $132M | Sell |
170,700
-14,000
| -8% | -$11.6M | 0.06% | 291 |
|
|
2024
Q3 | $164M | Sell |
184,700
-50,800
| -22% | -$45.7M | 0.08% | 232 |
|
|
2024
Q2 | $213M | Buy |
235,500
+1,500
| +0.6% | +$1.2M | 0.1% | 171 |
|
|
2024
Q1 | $182M | Buy |
234,000
+10,200
| +5% | +$7.26M | 0.08% | 231 |
|
|
2023
Q4 | $130M | Sell |
223,800
-60,400
| -21% | -$35.3M | 0.06% | 324 |
|
|
2023
Q3 | $153M | Buy |
284,200
+67,900
| +31% | +$35M | 0.08% | 188 |
|
|
2023
Q2 | $101M | Buy |
216,300
+87,800
| +68% | +$36.8M | 0.05% | 360 |
|
|
2023
Q1 | $44.1M | Buy |
128,500
+300
| +0.2% | +$101K | 0.03% | 772 |
|
|
2022
Q4 | $46.9M | Buy |
128,200
+81,400
| +174% | +$28.9M | 0.03% | 792 |
|
|
2022
Q3 | $15.1M | Sell |
46,800
-25,800
| -36% | -$8.17M | 0.01% | 1636 |
|
|
2022
Q2 | $23.5M | Sell |
72,600
-107,400
| -60% | -$32.2M | 0.01% | 1155 |
|
|
2022
Q1 | $51.5M | Buy |
180,000
+103,400
| +135% | +$26.6M | 0.03% | 671 |
|
|
2021
Q4 | $21.2M | Sell |
76,600
-79,800
| -51% | -$20.2M | 0.01% | 1397 |
|
|
2021
Q3 | $36.1M | Sell |
156,400
-97,600
| -38% | -$24.1M | 0.02% | 845 |
|
|
2021
Q2 | $58.3M | Buy |
254,000
+180,800
| +247% | +$36.3M | 0.04% | 539 |
|
|
2021
Q1 | $13.7M | Buy |
73,200
+53,500
| +272% | +$10.5M | 0.01% | 1462 |
|
|
2020
Q4 | $3.33M | Sell |
19,700
-16,000
| -45% | -$2.39M | ﹤0.01% | 2822 |
|
|
2020
Q3 | $5.28K | Sell |
35,700
-32,700
| -48% | -$5.06M | 0.01% | 1789 |
|
|
2020
Q2 | $11.2M | Sell |
68,400
-97,900
| -59% | -$15M | 0.02% | 1134 |
|
|
2020
Q1 | $23.1M | Buy |
+166,300
| New | +$22.8M | 0.05% | 393 |
|
|
2019
Q4 | – | Sell |
-4,400
| Closed | -$492K | – | 4454 |
|
|
2019
Q3 | $492K | Buy |
+4,400
| New | +$490K | ﹤0.01% | 3269 |
|
|
2019
Q2 | – | Sell |
-250,400
| Closed | -$32.5M | – | 4286 |
|
|
2019
Q1 | $32.5M | Buy |
250,400
+100,400
| +67% | +$12.2M | 0.05% | 530 |
|
|
2018
Q4 | $17.4M | Buy |
150,000
+50,000
| +50% | +$5.59M | 0.03% | 777 |
|
|
2018
Q3 | $10.7M | Sell |
100,000
-150,000
| -60% | -$15M | 0.01% | 1266 |
|
|
2018
Q2 | $21.3M | Buy |
+250,000
| New | +$20.5M | 0.03% | 816 |
|
|
2017
Q2 | – | Sell |
-150,000
| Closed | -$12.6M | – | 3679 |
|
|
2017
Q1 | $12.6M | Sell |
150,000
-430,000
| -74% | -$34.4M | 0.02% | 904 |
|
|
2016
Q4 | $42.7M | Buy |
580,000
+560,000
| +2,800% | +$41.7M | 0.09% | 316 |
|
|
2016
Q3 | $1.6M | Buy |
+20,000
| New | +$1.6M | ﹤0.01% | 2047 |
|
|
2016
Q2 | – | Sell |
-100,000
| Closed | -$7.2M | – | 3397 |
|
|
2016
Q1 | $7.2M | Buy |
+100,000
| New | +$7.57M | 0.02% | 1030 |
|
|
2015
Q4 | – | Sell |
-100,000
| Closed | -$8.37M | – | 3615 |
|
|
2015
Q3 | $8.37M | Sell |
100,000
-100,000
| -50% | -$8.44M | 0.02% | 1032 |
|
|
2015
Q2 | $16.7M | Hold |
200,000
| – | – | 0.03% | 710 |
|
|
2015
Q1 | $14.5M | Buy |
+200,000
| New | +$14.2M | 0.03% | 838 |
|
|
2014
Q4 | – | Sell |
-3,800
| Closed | -$246K | – | 4120 |
|
|
2014
Q3 | $246K | Sell |
3,800
-3,100
| -45% | -$196K | ﹤0.01% | 3245 |
|
|
2014
Q2 | $429K | Sell |
6,900
-44,400
| -87% | -$2.65M | ﹤0.01% | 2680 |
|
|
2014
Q1 | $3.02M | Buy |
+51,300
| New | +$2.86M | 0.01% | 1502 |
|
|
2013
Q4 | – | Sell |
-94,700
| Closed | -$4.77M | – | 3618 |
|
|
2013
Q3 | $4.77M | Buy |
94,700
+34,500
| +57% | +$1.81M | 0.02% | 1152 |
|
|
2013
Q2 | $2.96M | Buy |
+60,200
| New | +$3.28M | 0.01% | 1342 |
|
Other funds holding LLY
VCM
VPM
Millennium Management's LLY Position: Q1 2026 in Review
Millennium Management reduced its Eli Lilly (LLY) stake by 18% in Q1 2026, selling an estimated $59.7M and leaving 275,989 shares worth $254M. The position accounts for 0.11% of the portfolio, ranked #165.
Millennium Management first reported a position in LLY in Q2 2013 and has held it in 50 quarters since. The position peaked at $877M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Millennium Management held 275,989 shares of Eli Lilly worth $254M as of Q1 2026.
- Millennium Management sold 58,869 Eli Lilly shares in Q1 2026, an estimated $59.7M.
- Eli Lilly made up 0.11% of Millennium Management's portfolio in Q1 2026, its #165 holding.
- Millennium Management first reported a position in Eli Lilly in Q2 2013 and has held it in 50 quarters since.
- Millennium Management's Eli Lilly position peaked at $877M in Q3 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.